Objective: To evaluate the in vitro cytotoxic potential of CELNORM, a nutritional health supplement, on MCF7 human adenocarcinoma breast cancer cells. Methods: Briefly, MCF7 cells were cultured for 24 hours in complete growth medium containing fetal bovine serum and antibiotics and exposed to various concentrations (500, 250, 125, 62.5, 31.25, 15.625, 7.8125, 3.906 micrograms/mL) of CELNORM for a period of 24 hours. Cell viability/death was assessed qualitatively by microscopy and quantitatively by MTT assay. Findings: CELNORM exhibited significant cytotoxic effect on MCF-7 cells in a dose dependent manner. Under microscopy, there was an evident, dosedependent increase in the number of apoptotic cells. Cell viability exhibited in terms of percentage viability, fell below 70% from 7.9 µg/mL, which is indicative of cytotoxic response from this dose. The IC 50 value was determined to be 43.51 µg/mL. Applications: With such an effective combination of natural ingredients, the results are promising. Therefore, we conclude that CELNORM can be a useful option in the supplemental therapy for breast cancer treatment in the panel of Complementary and Alternative Medicine (CAM).